MERCK & CO., INC.

(MRK)
  Report
Delayed Nyse  -  05/20 04:03:28 pm EDT
93.55 USD   +1.59%
05/20Merck's Keytruda Receives Positive EMA Panel Opinion as Adjuvant Therapy in Skin Cancer
MT
05/20Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Adolescent (≥12 Years of Age) Patients With Stage IIB or IIC Melanoma Following Complete Resection
BU
05/20Merck Gets CHMP Backing for Expanded Keytruda Use in Melanoma
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about MERCK & CO., INC.
05/20Merck's Keytruda Receives Positive EMA Panel Opinion as Adjuvant Therapy in Skin Cancer
MT
05/20Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treat..
BU
05/20Merck Gets CHMP Backing for Expanded Keytruda Use in Melanoma
DJ
05/17Calliditas Therapeutics Starts Enrollment of Mid-Stage Head and Neck Cancer Study
MT
05/17Berenberg Bank Adjusts Merck's Price Target to $95 From $87, Maintains Hold Rating
MT
05/16Neoleukin Therapeutics Treats First Tumor Patient in Trial Evaluating NL-201 With Keytr..
MT
05/16Athenex, Merck Collaborate to Study Oraxol Plus Keytruda in Non-Small Cell Lung Cancer
MT
05/16Athenex, Inc. Announces Clinical Collaboration with Merck to Evaluate Oraxol Plus KEYTR..
CI
05/16Rising Cyber Attacks Could Make Insurance Unaffordable
AQ
05/13Tesla, Occidental rise; New Relic, Merck fall
AQ
05/12Thinking about trading options or stock in Hess, Electronic Arts, Merck, Microsoft, or ..
PR
05/11TRANSCRIPT : Merck & Co., Inc. Presents at Bank of America 2022 Healthcare Conference, May..
CI
05/10SECTOR UPDATE : Health Care Stocks Still Edging Higher This Afternoon
MT
05/10Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medic..
BU
05/10Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medic..
CI
05/05MERCK & CO., INC. Management's Discussion and Analysis of Financial Condition and Resu..
AQ
05/05Nabriva Therapeutics Signs Extended Deal With Merck to Promote, Distribute Sivextro Thr..
MT
05/05Nabriva Extends Exclusive Agreement to Promote and Distribute Sivextro® (Tedizolid Phos..
CI
05/04Amphista Therapeutics Announces Strategic Collaboration with Merck Healthcare, Division..
CI
05/04Merck to Participate in Bank of America Securities 2022 Healthcare Conference
BU
05/02Merck - European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy..
AQ
05/02Merck - European Commission Approves Merck's KEYTRUDA (pembrolizumab) for Patients With..
AQ
05/02Thinking about trading options or stock in Merck, Tesla, Netflix, Advanced Micro Device..
PR
05/02UNIVERSITY OF CHICAGO : A new technique to delete single atoms can speed up molecule desig..
AQ
05/01Imugene Limited Announces Termination of Supply Agreement
CI
04/29Morgan Stanley Adjusts Merck & Co.'s Price Target to $87 from $80, Keeps Equalweight Ra..
MT
04/29Goldman Sachs Adjusts Price Target for Merck & Company to $105 From $101, Maintains Buy..
MT
04/29JPMorgan Adjusts Price Target for Merck & Company to $100 From $95, Maintains Overweigh..
MT
04/29Wells Fargo Raises Merck & Company's Price Target to $105 From $90, Reiterates Overweig..
MT
04/29SVB Leerink Adjusts Merck & Co.'s Price Target to $102 from $97, Keeps Outperform Ratin..
MT
04/29Merck & Co. Receives EU Approval for Cancer Immunotherapy Keytruda
MT
04/29Merck Says EC Approves Keytruda Regimen to Treat Advanced Cervical Cancer
MT
04/29Ionova Life Science Co., Ltd. Announces Clinical Trial Collaboration with Merck & Co., ..
CI
04/29European Commission Approves Merck's KEYTRUDA® (pembrolizumab) for Patients With Micros..
BU
04/29European Commission Approves Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With ..
BU
04/29Merck Gets Expanded Europe OK for Keytruda in Cervical Cancer
DJ
04/29AstraZeneca Moves to Secure Long-Term Growth With New R&D Hub Amid Expected Drop in COV..
MT
04/28COVID-19 treatment, Keytruda boost drugmaker Merck in Q1
AQ
04/28Merck & Co. Lifts 2022 EPS, Sales Guidance
MT
04/28MERCK : 1Q22 Merck Earnings Presentation
PU
04/28TRANSCRIPT : Merck & Co., Inc., Q1 2022 Earnings Call, Apr 28, 2022
CI
04/28MERCK : Announces First-Quarter 2022 Financial Results - Form 8-K
PU
04/28Merck Posts Higher Q1 Adjusted Earnings, Sales; Raises Full-Year 2022 Outlook
MT
04/28MERCK : Q1 Earnings Snapshot
AQ
04/28GUIDANCE : (MRK) MERCK & CO. Sees Fiscal Year 2022 EPS Range $7.24 - $7.36
MT
04/28GUIDANCE : (MRK) MERCK & CO. Expects Fiscal Year 2022 Revenue Range $56.9B - $58.1B
MT
04/28Earnings Flash (MRK) MERCK & CO. Reports Q1 Revenue $15.9B
MT
04/28Earnings Flash (MRK) MERCK & CO. Reports Q1 EPS $2.14
MT
04/28Merck Announces First-Quarter 2022 Financial Results
BU
04/28Merck & Co., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/28Merck & Co., Inc. Provides Earnings Guidance for the Year 2022
CI
04/26Merck Receives Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) Plus Chemotherapy ..
AQ
04/25Merck Receives EU Recommendation For Triple-negative Breast Cancer Treatment Approval
MT
04/25Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy..
BU
04/25Merck Receives Positive EU Chmp Opinion for Keytruda(R) (Pembrolizumab) Plus Chemothera..
CI
04/25Merck Gets CHMP Backing for Expanded Keytruda Use in Breast Cancer
DJ
04/22Pfizer Wins WHO Endorsement For Antiviral Pill In High-Risk COVID-19 Patients
MT
04/21PLEADING AND PREEMPTION : Immunization Against Vaccine Products Liability Claims
AQ
04/21SVB Leerink Adjusts Merck & Co.'s Price Target to $97 From $100, Keeps Outperform Ratin..
MT
04/21MERCK : Asset Acquisition - Form 8-K
PU
04/21MERCK & CO., INC. : Results of Operations and Financial Condition, Other Events, Financial..
AQ
04/20Merck Announces That Joseph Romanelli Will Lead Merck Human Health International, Effec..
BU
04/18Health Canada Approves KEYTRUDA® (pembrolizumab) for the treatment of adult patients wi..
AQ
04/18Merck Receives Approval from Health Canada for KEYTRUDA
CI
04/14Merck Receives FDA Breakthrough Therapy Designation for Pneumococcal Conjugate Vaccine
MT
04/14Merck Announces U.S. FDA has Granted Breakthrough Therapy Designation for V116, the Com..
BU
04/14Merck Gets FDA Breakthrough Therapy Designation for V116 Vaccine
DJ
04/12Barclays Adjusts Price Target for Merck & Company to $97 From $94, Maintains Overweight..
MT
04/12Goldman Sachs Adjusts Price Target for Merck & Company to $101 From $93, Maintains Buy ..
MT
04/11Merck Says Health Canada Expands HPV Vaccine Gardasil 9's Marketing Authorization
MT
04/11Health Canada Approves GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) ..
AQ
04/11Health Canada Approves Merck & Co., Inc.'s Gardasil®9 for the Prevention of Oropharynge..
CI
04/11Merck Gets Approval to Expand Gardasil Indication in Canada
DJ
04/08Merck to Hold First-Quarter 2022 Sales and Earnings Conference Call April 28
BU
04/06Morgan Stanley Adjusts Merck & Co.'s Price Target to $80 from $82, Keeps Equalweight Ra..
MT
1  2  3  4  5  6  7  8  9  10Next
Official Publications
Upcoming event on MERCK & CO., INC.